1. There should be only one standard of quality, safety and efficacy of medicines, whether these are produced for local consumption or for export only. Member States should regulate drugs for export in accordance with appropriate international standards.
2. WHO should collaborate closely with the PIC/S to enhance capacity building of national inspectorates. This could be undertaken within the concept of a Global Alliance for Quality of Medicines.
3. WHO should continue its efforts towards the development of international specifications and pharmacopoeial requirements and the establishment of international reference standards for drugs responding to major public health needs.
4. In collaboration with Member States, WHO should develop guidelines for the regulation of xenotransplantation.